Paxton Major

Paxton Major is a Director at Northpond Ventures. He joined Northpond in August 2018 as a member of the investment team, helping lead investments in biopharma R&D tools, precision medicine, and digital health. Paxton is a board director at Kytopen, Molecule, QbD Vision, Teckro, and Torus Biosystems. Some of his active and past board observer roles include Elephas, Scitara, Selux Diagnostics, SimBioSys, Syapse, VieCure, Current Health (acquired by BBY), and NanoView (acquired by Unchained Labs). Previously, Paxton was a consultant at Trinity Partners, a life science-focused strategy and management consultancy that advises clients by providing in-depth market, competitor, customer, and financial insights. Paxton earned a B.S. with honors in neurobiology from Brown University.